Back to search

Democritus University of Thrace (DUTH)

Ανοσοϊστοχημική μελέτη εξωλεμφαδενικών μη Hodgkin λεμφωμάτων με CD95(FAS), BCL2, P53 και συσχέτιση των αποτελεσμάτων με την πρόγνωση της νόσου

Abstract

dc:description

Purpose The aim was to study extranodal non-Hogdkin’s lymphomas about theimmunohistochemical expression of CD95, BCL2 and P53, it’s correlation withclinical parameters and it’s prognostic significance.Materials and methods The present study included 81 extranodal non-Hodgkin’slymphomas. The majority of them were DLBCL (N=45) and MALTL (N=26). Weinvestigated the immunohistochemical expression of CD95, BCL2 and P53 and theresults correlated with clinical parameters and survival.Conclusions - In DLBCL: Absence of B-symptoms, normal serum LDH levels andearly stages of disease are independent favourable prognostic factors. Patients withIPI score 0-2 had higher survival than the ones with IPI score 3-5. CD95 positivitywas more frequent in stages I-II, and BCL2 positivity in stages III-IV. GI lymphomashad better prognosis compared to the ones of other sites (tonsils excluded). CD95expression proved to be an independent statistically significant favourable prognosticfactor in predicting the survival. BCL2 expression found to be an independentstatistically significant unfavourable prognostic factor in predicting the survival.There was no statistically significant difference in the overall survival between theP53-positive and P53-negative groups. However, although the expression of P53 didnot appear to be of prognostic significance, there was still a clear trend that the P53-immunopositive patients tend to die sooner than the patients with P53-negativetumors. The combined expression of P53 and BCL2 correlated with poorer prognosisthan the expression of only P53 or BCL2.- In MALTL: Absence of B-symptoms, normal serum LDH levels, < 2 extranodalsites of involvment and early stages of disease are independent favourable prognosticfactors. Patients with IPI score 0-2 had higher survival than the ones with IPI score 3-5. CD95 expression seemed to be an independent statistically significant favourableprognostic factor in predicting the survival. P53 expression proved to be anindependent statistically significant unfavourable prognostic factor in predicting thesurvival. There hasn’t been found any prognostic statistical significance of BCL2expression. For all that, patients with BCL2-negative MALTL tend to live more thanthe positive ones. Patients with P53-,BCL2- phenotype had higher 5-year overallsurvival rate, comparing to patients with concomitant expression P53 and BCL2.

Degree

thesis:*
Grantor dc:publisher
Democritus University of Thrace (DUTH)
Year dc:date
2011

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Chatzitolios, Anastasios
  • Χατζητόλιος, Αναστάσιος

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/30324

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Chatzitolios, Anastasios; Χατζητόλιος, Αναστάσιος. Ανοσοϊστοχημική μελέτη εξωλεμφαδενικών μη Hodgkin λεμφωμάτων με CD95(FAS), BCL2, P53 και συσχέτιση των αποτελεσμάτων με την πρόγνωση της νόσου. Democritus University of Thrace (DUTH), 2011. http://hdl.handle.net/10442/hedi/30324